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Abstract
Background: Acute idiopathic pericarditis (AIP) is frequently accompanied by myocardial involve-
ment (AIPM). Although in acute myocarditis, the myocardial inflammation can lead to life-threatening 
complications, the outcome of patients with AIPM has been described as good. It remains unclear if  
a good prognosis of patients with AIPM reflects mild myocardial involvement or good medical management.
Methods: A retrospective analysis of life-threatening complications and life-saving interventions in 
a cohort of 248 consecutive patients admitted to a single medical center between 2006 and 2017 with 
AIP (n = 169) or AIPM (n = 79). Major adverse cardiac events (MACE) included cardiac tamponade, 
cardiogenic shock, ventricular tachycardia, pericardiocentesis, pericardiectomy, large pericardial effu-
sion and death. 
Results: Patients with AIPM were younger than patients with AIP (p < 0.001), and more often had 
left ventricular dysfunction (31.6% vs. 1.2%, p < 0.001) and less often had large pericardial effusion 
(1.3% vs. 13.6%, p = 0.002), and MACE (5.1% vs. 14.8%, p = 0.014). Cardiac tamponade occurred 
in 5.3% of the patients with AIP as opposed to 1.3% of the patients with AIPM (p = 0.176). Severe left 
ventricular dysfunction with cardiogenic shock occurred exclusively among patients with AIPM but the 
rate was low (2.5%). Life-saving interventions were used in both groups at comparable rates (2.5% vs. 
5.3%, p = 0.510). There were no in-hospital deaths.
Conclusions: Myocardial involvement in acute pericarditis is associated with a low rate of severe left 
ventricular dysfunction and cardiogenic shock and a reduced rate of large pericardial effusion, result-
ing in a lower rate of MACE. Life-saving interventions were used at comparable rates in patients with 
and without myocardial involvement having excellent survival rates. (Cardiol J XXXX; XX, X: xx–xx)
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Introduction
Myocardial involvement has been reported in 
14.6% to 60.9% of patients with acute pericarditis 
[1–9]. The severity of the myocardial involvement, 
referred to by some authors as concomitant myo-
carditis [1], may vary from minimal elevation of a 
myocardial biomarker level with or without mild 
left ventricular (LV) dysfunction to severe LV dys-
function and ultimately hemodynamic compromise. 
Although the natural history, characteristics, and 
outcomes of acute idiopathic pericarditis (AIP) and 
of acute myocarditis have been studied extensively 
[1, 10–13], the data for acute pericarditis with 
myocardial involvement (AIPM) are limited [2–6]. 
In acute myocarditis, myocardial inflammation can 
lead to life-threatening complications, including 
severe LV dysfunction, heart failure, cardiogenic 
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shock, ventricular tachycardia and atrioventricular 
block [10–13]. Recently, an in-hospital rate of death 
or heart transplant of 3.2% has been reported [13]. 
The long-term outcome of patients with acute peri-
carditis has been described as good, with and with-
out myocardial involvement [3]. However, little is 
known about the rate of acute phase complications, 
and it remains unclear whether a good prognosis of 
patients with AIPM is related to a low rate of severe 
complications or use of life-saving interventions. 
Moreover, the finding that the outcome of patients 
with AIPM is not poorer than patients with acute 
pericarditis without myocardial involvement is in-
triguing. The purpose of this study was to examine 
why myocardial involvement in acute pericarditis is 
not associated with worse outcomes although it can 
lead to LV dysfunction. For this purpose, outcomes 
of patients with acute idiopathic pericarditis were 
compared with and without myocardial involve-
ment admitted to the documented hospital over 
an 11-year period and possible differences were 
examined in acute phase complications and the use 
of life-saving interventions.
Methods
The computerized database of the medical 
center was searched for patients hospitalized 
between March 1, 2006 and March 1, 2017 with a 
first episode of AIP or AIPM in whom the diagno-
sis complied with current guidelines [1]. Patient 
electronic medical files were retrospectively re-
viewed for data on mortality, clinical, laboratory 
and imaging parameters, major adverse cardiac 
events (MACE), life-saving interventions, and 
findings on follow-up. 
The diagnosis of AIP was based on the pres-
ence of at least two of the following criteria: typical 
chest pain, friction rub, new or worsening peri-
cardial effusion, and typical electrocardiographic 
changes [1]. Patients in whom a specific etiology 
for the pericarditis was identified (for example, 
rheumatoid arthritis, systemic lupus erythema-
tosus, familial Mediterranean fever, tuberculosis, 
post-myocardial injury syndrome, chronic renal 
failure, purulent pericarditis, and acute or recent 
myocardial infarction) were excluded from the 
study. Patients with active malignancy, pregnant 
patients, and patients referred from other hospitals 
were also excluded. 
The criteria for the diagnosis of AIPM were 
the presence of diagnostic criteria for AIP and 
elevation of cardiac troponin T (cTnT) level in the 
presence of a normal serum creatinine level, or 
an elevated creatine phosphokinase level in the 
presence of an elevated serum creatinine level.
The size of the pericardial effusion was as-
sessed by echocardiography and categorized semi-
quantitatively as small, moderate, or large. LV 
global function and regional wall motion abnor-
malities were assessed using either echocardiog-
raphy or cardiac magnetic resonance angiography. 
Impaired LV function was defined as an abnormal 
global systolic function or wall motion abnormality. 
LV systolic function was semi-quantitatively cat-
egorized as normal, mildly, moderately or severely 
decreased. Peak white blood cell count on the first 
day of admission, peak body temperature, and peak 
C-reactive protein level were recorded. Exclusion 
of significant coronary artery disease was done in 
all patients with myocardial involvement except 
those at very low risk, using coronary angiography 
or computed tomographic coronary angiography. 
The idiopathic nature of the disease was proved 
by lack of evidence for a specific etiology during 
hospital stay and on follow-up. Pericardial fluid was 
analyzed in all the patients when obtained. 
The following were categorized as MACE: 
cardiac tamponade, non-obstructive cardiogenic 
shock, ventricular tachycardia, large symp-
tomatic pericardial effusion, atrioventricular 
block and death. The following were recorded 
as life-saving interventions: pericardiocenthe-
sis or surgical evacuation of pericardial fluid for 
treatment of cardiac tamponade, cardioversion 
for sustained ventricular tachycardia, use of 
intra-aortic balloon counter-pulsation device, 
use of extracorporeal mechanical oxygenator, and 
intensive intravenous catecholamine administra-
tion with intraarterial pressure monitoring for 
cardiogenic shock.
The study was approved by the local institu-
tional ethics committee. 
Statistical analysis
Categorical variables are described as num-
bers and percentages. Continuous variables were 
evaluated for normal distribution using histograms 
and Q-Q plots and are reported as median and 
interquartile range. Categorical variables were 
compared between groups using the c2 test or the 
Fisher exact test. Continuous variables were com-
pared using the Kruskal-Wallis test and the Mann-
Whitney test. A p value of < 0.05 was considered 
significant. All statistical tests were performed 
using SPSS version 21.
2 www.cardiologyjournal.org
Cardiology Journal XXXX, Vol. XX, No. X
Results
The study group included 248 patients (76% 
male) aged 18–89 years (median, 47 years). Myo-
cardial involvement was found in 79 of them (32%) 
and they were categorized as AIPM. Patient base-
line characteristics by group are depicted in Table 1. 
Compared to the AIP group, the AIPM group was 
characterized by younger age, lower rate of moder-
ate and large pericardial effusion, higher propor-
tion of LV dysfunction and lower white blood cell 
count and they were less often given glucocorticoid 
therapy.  
Table 2 shows the rates of in-hospital com-
plications and of use of life-saving interventions. 
Patients with AIPM had a lower frequency of 
large symptomatic pericardial effusion. MACE 
was observed in 30 (12.1%) of the 248 patients. 
The frequency of MACE was lower in patients 
with AIPM than in patients with AIP. Severe LV 
dysfunction and cardiogenic shock occurred only 
in patients with AIPM but the difference was not 
statistically significant.
There were no in-hospital deaths. However, 
life-saving interventions were used in 11 (4.4%) 
patients: 10 patients underwent evacuation of 
the pericardial fluid for cardiac tamponade (9 had 
pericardiocentesis, 1 had surgical evacuation) and 
2 patients with cardiogenic shock needed me-
chanical hemodynamic support (1 extracorporeal 
oxygenator, 1 intra-aortic balloon counter-pulsation 
device. One of these patients needed both pericar-
diocentesis and mechanical support.) Among the 
Table 1. Baseline characteristics by group.
AIP  
(n = 169) 
AIPM  
(n = 79)
P
Age: < 0.001
25 39.0 26.0
50 53.0 35.0
75 66.0 45.0
Male gender 124 (73.4) 65 (82.3) 0.150
Pericardial effusion: 118 (69.8) 46 (58.2) 0.084
None 49 (29.3) 33 (41.8) 0.060
Small 53 (31.7) 35 (44.3) 0.064
Moderate 45 (36.9) 10 (14.9) 0.020
Large 22 (14.9) 1 (1.3) 0.002
Moderate or larger 67 (39.6) 11 (13.9) < 0.001
Biomarker elevation 0 (0.0) 79 (100.0) <0.001
LV dysfunction 2 (11.8) 25 (31.6) < 0.001
CRP: 0.098
25 0.0 3.7
50 11.3 7.15
75 17.2 16.7
WBC: 0.005
25 9090 6575
50 11300 8515
75 13350 12775
Prednisone 53 (31.4) 6 (7.6) < 0.001
Data on age, C-reactive protein (CRP) and white blood cell count 
(WBC) are medians and percentile 25 and 75 values. All other data 
are presented as number (percentage). AIP — acute idiopathic 
pericarditis; AIPM — acute idiopathic pericarditis with myocardial 
involvement; LV — left ventricular
Table 2. Complications and life-saving interventions by group. 
AIP (n = 169) AIPM (n = 79) P
Large symptomatic pericardial effusion 22 (14.9) 1 (1.3) 0.002
Severe LV dysfunction 0 (0) 2 (2.5) 0.102
Cardiogenic shock 0 (0.0) 2 (2.5) 0.102
Tamponade 9 (5.3) 1 (1.3) 0.176
Pericardial fluid evacuation 10 (5.9) 1 (1.3) 0.182
VT/NSVT 0 (0.0) 0 (0.0) > 0.999
Syncope 2 (1.2) 1 (1.3) > 0.999
In-hospital death 0 (0%) 0 (0%) > 0.999
Major adverse cardiac events 26 (15.4) 4 (5.1) 0.002
Life-saving interventions 9 (5.3) 2 (2.5) 0.510
Data are presented as number (percentage). AIP — acute idiopathic pericarditis; AIPM — acute idiopathic pericarditis with myocardial involve-
ment; LV — left ventricular; VT — ventricular tachycardia; NSVT — non-sustained ventricular tachycardia
www.cardiologyjournal.org 3
Aviv Mager et al., Significance of myocardial involvement in acute pericarditis
patients with AIPM, 25 had impaired LV function 
and thus, met the criteria for perimyocarditis [3]. 
There was no difference in the rate of life saving 
interventions in this group, 8%, and the group of 
patients with AIP (5.3%, p = 0.637). Pericardial 
fluid analysis did not reveal a specific etiology in 
any of the patients.   
Discussion 
The results of this retrospective analysis of 
consecutive patients with acute idiopathic pericar-
ditis show, for the first time, that acute pericarditis 
with myocardial involvement is characterized by 
lower rates of large pericardial effusion and MACE. 
Severe LV dysfunction and cardiogenic shock may 
develop in patients with AIPM, necessitating life-
threatening interventions. However, the rate is 
low and does not significantly increase the rate of 
MACE. The rates of use of life-saving interventions 
in patients with and without myocardial involve-
ment are comparable, resulting in a good survival 
rate for both groups.
Data in the literature regarding the in-hospital 
course of patients with myocardial involvement 
are very limited [3–5]. A good survival rate in the 
present relatively large cohort of patients is in 
agreement with results of previous reports [4, 5]. 
However, previous reports provided only limited 
information on life-threatening complications and 
use of life-saving interventions in patients with 
myocardial involvement. As the current findings 
show, life-threatening complications occurred in 
both groups at comparable rates. Because both 
cardiac tamponade and cardiogenic shock are as-
sociated with high mortality rates if untreated, 
the good outcomes of the present patients with 
acute pericarditis, with and without myocardial 
involvement, reflects the success of life-saving 
interventions rather than a benign natural history.
Although severe LV dysfunction and cardio-
genic shock occurred exclusively among patients 
with AIPM, the proportion of patients with AIPM 
in need of life-saving interventions in hospital 
was not higher than in AIP patients. This was ex-
plained by the low frequency of this complication, 
together with a very low rate of cardiac tamponade 
and need for evacuation of pericardial fluid in the 
patients with AIPM. The difference in the rate of 
cardiac tamponade between patients with AIP and 
AIPM was not statistically significant. However, 
the significantly lower rates of large and moder-
ate pericardial effusion among patients with AIPM 
indicate that patients with AIPM are at lower risk of 
cardiac tamponade. Thus, the lower rate of cardiac 
tamponade in the present patients with AIPM was 
probably a true finding. 
The absence of atrioventricular block in the 
present patients was not surprising, as this com-
plication was found to rarely occur in inflammatory 
cardiac syndromes [3].  Previous reports have 
demonstrated that myocardial involvement affects 
younger patients [2, 3, 5]. The younger age of the 
current patients with AIPM is in agreement with 
these findings. Interestingly, younger age is typi-
cal to acute myocarditis as well [14], supporting 
the hypothesis that the myocardial involvement in 
acute pericarditis reflects concomitant myocarditis. 
Unlike most previous reports, only patients 
with idiopathic syndromes were included herein. 
All patients lived in the same geographic region 
and acquired the disease during the same period 
of time. Thus, it is unlikely that our results were 
biased by shifts in the viral spectrum [15], envi-
ronmental or genetic factors.
A larger proportion of the patients with AIP 
received prednisone therapy. Although prednisone 
therapy is believed to favorably affect the hospital 
course, MACE occurred more frequently among 
the patients with AIP. Thus, the less frequent use 
of prednisone in the current patients with AIPM 
did not account for the lower rate of MACE in this 
group.
Conclusions
Myocardial involvement in patients with acute 
idiopathic pericarditis is associated with a low rate 
of severe LV dysfunction and a decreased rate of 
large pericardial effusion as compared to patients 
without myocardial involvement. These result 
in comparable rates of life-threatening complica-
tions and of the use of life-saving interventions in 
patients with acute pericarditis with and without 
myocardial involvement. Thus, a good prognosis 
of patients with AIPM despite the occurrence of 
severe LV dysfunction is explained at least in part 
by the successful use of life-saving interventions. 
Because severe LV dysfunction may occasionally 
occur in AIPM, assessment of LV function and 
adequate monitoring in these patients are neces-
sary. More research is necessary to clarify whether 
myocardial involvement is a complication of acute 
pericarditis or represents a different variant of 
inflammatory cardiac syndrome characterized by 
concomitant pericarditis and myocarditis. 
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